Cargando...
Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
The quadrivalent HPV vaccine (4vHPV) was originally recommended as a three-dose series (0/2/6 months), though delays in completing the series frequently occur. We previously found delayed dosing in girls resulted in similar or higher antibody titers compared to on-time dosing. Archived sera from 262...
Gardado en:
| Publicado en: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7482794/ https://ncbi.nlm.nih.gov/pubmed/31967933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1706410 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|